Individuals who receive injections often report improved energy levels, enhanced cognitive function, and better mood within days of starting treatment
Pentadeca Arginate (BPC-157 Arginate) has not been approved by the FDA for the treatment, prevention, or cure of any disease
Does It Affect Clotting
Symptoms (fatigue, weakness), physical exam notes, and lab test results such as CBC and ferritin levels
The FDA declared the tirzepatide shortage over in December 2024 and the semaglutide shortage over in February 2025 which should have ended pharmacies' ability to legally compound "copy" versions of the drugs, according to FDA guidance
Topical and nutricosmetic products for healthy hair and dermal anti-aging using "dual-acting" (2 for 1) plant-based peptides, hormones, and cannabinoids